Versatope Therapeutics headquarters details
- Street address
- 110 Canal St
- City
- Lowell
- State / region
- Massachusetts
- ZIP / postal code
- 01852-4574
- Country
- United States
- Phone
- +1 781 879 3119
- Founded
- 2017
- Website
- versatope.com
- linkedin.com/company/versatope
Location map
Open in Google MapsAll Versatope Therapeutics office locations
| City | State / region | Country | Type |
|---|---|---|---|
| Lowell HQ | Massachusetts | United States | Headquarters |
About Versatope Therapeutics
Versatope Therapeutics is headquartered in Lowell, Massachusetts, United States. Founded in 2017, the company employs approximately 35 people worldwide.
Where is Versatope Therapeutics's main office?
Versatope Therapeutics's main headquarters office is located at 110 Canal St, Lowell, Massachusetts 01852-4574, United States. This is the company's primary corporate address.
Versatope Therapeutics contact information
The main switchboard for Versatope Therapeutics headquarters can be reached at +1 781 879 3119. Official website: versatope.com.
What does Versatope Therapeutics do?
Versatope Therapeutics is an infectious disease company with two lead development programs and others at the preclinical stage. Versatope delivers immunity by customizing nano-size vesicles by using synthetic biology for biopharmaceutical applications.
Frequently asked questions
Where is Versatope Therapeutics headquarters?
Versatope Therapeutics's headquarters is located at 110 Canal St, Lowell, Massachusetts 01852-4574, United States.
What is Versatope Therapeutics's corporate address?
The corporate headquarters address is 110 Canal St, Lowell, Massachusetts 01852-4574, United States.
When was Versatope Therapeutics founded?
Versatope Therapeutics was founded in 2017 and employs approximately 35 people.
What is Versatope Therapeutics's phone number?
The main phone number for Versatope Therapeutics headquarters is +1 781 879 3119.
How many employees does Versatope Therapeutics have?
Versatope Therapeutics has approximately 35 employees (GraphIQ estimate, 2026).